Sergio Traversa, Chief Executive Officer at RELMADA THERAPEUTICS, INC. (RLMD), bought 272,500 shares at $2.20 ($600K) on 2025-11-05, disclosed to the SEC on 2025-11-06.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| RLMD | BUY | 2025-08-28 | $265K | — | Filing → |
| RLMD | BUY | 2025-05-20 | $335K | — | Filing → |
| RLMD | BUY | 2024-09-11 | $790K | — | Filing → |